A study for a 73 year old woman who takes Enzyme Therapy (an AI-powered real world drug study)

---

---

Number of reports submitted per year:

Information of the patient in this study:

• Age: 73
• Gender: female

---

Comparison with patient's specific adverse outcomes:

You can check what is more associated with an adverse outcome: a drug mix, a drug, a condition, or a population of certain gender and age. Each patient is different. It is not uncommon that the results can be inconclusive or insignificant.

By the same drug(s):

• Enzyme Supplementation:
  - among females aged 73 (±5) who take the same drug: 0% (0 of 556)
  - among people who take the same drug, regardless of gender or age: 0% (0 of 6,856)

By each condition:

By each drug (FDA data only):

• people who take Enzyme Therapy and have Enzyme Supplementation:
  - among females aged 73 (±5) who take Enzyme Therapy and have side effects: 0% (0 of 0)
  - among people who take Enzyme Therapy and have side effects, regardless of gender or age: 0% (0 of 0)

Common side effects *:

1. Diarrhea : 68 people, 12.23%
2. Fatigue (feeling of tiredness): 53 people, 9.53%
3. Nausea (feeling of having an urge to vomit): 50 people, 8.99%
4. Weakness : 36 people, 6.47%
5. Dizziness : 35 people, 6.29%
6. High Blood Pressure : 34 people, 6.12%
7. Constipation : 31 people, 5.58%
8. Nausea And Vomiting : 29 people, 5.22%
9. Thrombocytopenia (decrease of platelets in blood): 27 people, 4.86%
10. Pneumonia : 27 people, 4.86%
11. Dyspnea (difficult or laboured breathing): 24 people, 4.32%
12. Anaemia (lack of blood): 24 people, 4.32%
13. Drug Ineffective : 24 people, 4.32%
14. Joint Pain : 21 people, 3.78%
15. Headache (pain in head): 21 people, 3.78%
16. Rashes (redness): 20 people, 3.60%
17. Hypokalemia (low potassium): 20 people, 3.60%
18. Fever : 20 people, 3.60%
19. Fall : 19 people, 3.42%
20. Malaise (a feeling of general discomfort or uneasiness): 19 people, 3.42%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

1. High Blood Pressure : 65 people, 11.69%
2. Pain : 41 people, 7.37%
3. Constipation : 38 people, 6.83%
4. Diabetes : 34 people, 6.12%
5. Nausea (feeling of having an urge to vomit): 34 people, 6.12%
6. High Blood Cholesterol : 33 people, 5.94%
7. Multiple Myeloma (cancer of the plasma cells): 26 people, 4.68%
8. Type 2 Diabetes : 25 people, 4.50%
9. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 24 people, 4.32%
10. Back Pain : 21 people, 3.78%
11. Diarrhea : 21 people, 3.78%
12. Osteoporosis (bones weak and more likely to break): 20 people, 3.60%
13. Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 20 people, 3.60%
14. Insomnia (sleeplessness): 20 people, 3.60%
15. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 18 people, 3.24%
16. Ovarian Cancer (cancer of ovary): 18 people, 3.24%
17. Pneumonia : 17 people, 3.06%
18. Depression : 16 people, 2.88%
19. Hyperlipidaemia (presence of excess lipids in the blood): 15 people, 2.70%
20. Pancreatic Carcinoma Metastatic (pancreatic cancer- metastatic): 15 people, 2.70%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

1. Omeprazole (43 people, 7.73%)
2. Pantoprazole (35 people, 6.29%)
3. Ondansetron (31 people, 5.58%)
4. Vitamin D3 (30 people, 5.40%)
5. Miralax (28 people, 5.04%)
6. Acetaminophen (26 people, 4.68%)
7. Dexamethasone (26 people, 4.68%)
8. Synthroid (25 people, 4.50%)
9. Metformin (23 people, 4.14%)
10. Furosemide (23 people, 4.14%)
11. Spironolactone (23 people, 4.14%)
12. Aspirin (22 people, 3.96%)
13. Amlodipine (21 people, 3.78%)
14. Magnesium (21 people, 3.78%)
15. Calcium (19 people, 3.42%)
16. Potassium (19 people, 3.42%)
17. Eliquis (19 people, 3.42%)
18. Imodium (18 people, 3.24%)
19. Tylenol (17 people, 3.06%)
20. Creon (16 people, 2.88%)

Drug effectiveness *:

---